Black Diamond Therapeutics, Inc. financial data

Symbol
BDTX on Nasdaq
Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 778% % 19%
Debt-to-equity 29% % -22%
Return On Equity 18% %
Return On Assets 14% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 56,974,913 shares 0.69%
Common Stock, Shares, Outstanding 56,943,413 shares 0.75%
Entity Public Float $210,171,555 USD 83%
Common Stock, Value, Issued $8,000 USD 14%
Weighted Average Number of Shares Outstanding, Basic 56,929,103 shares 0.74%
Weighted Average Number of Shares Outstanding, Diluted 56,929,103 shares 0.74%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $39,559,000 USD -27%
General and Administrative Expense $18,584,000 USD -31%
Operating Income (Loss) $11,857,000 USD 39%
Nonoperating Income (Expense) $9,641,000 USD 17%
Income Tax Expense (Benefit) $226,000 USD
Net Income (Loss) Attributable to Parent $21,498,000 USD 45%
Earnings Per Share, Basic 0 USD/shares 46%
Earnings Per Share, Diluted 0 USD/shares 46%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $30,864,000 USD 32%
Assets, Current $138,992,000 USD 20%
Property, Plant and Equipment, Net $1,128,000 USD -23%
Operating Lease, Right-of-Use Asset $16,669,000 USD -16%
Other Assets, Noncurrent $117,000 USD -60%
Assets $157,733,000 USD 14%
Accounts Payable, Current $975,000 USD -51%
Employee-related Liabilities, Current $2,367,000 USD -44%
Accrued Liabilities, Current $14,570,000 USD -23%
Liabilities, Current $15,545,000 USD -25%
Operating Lease, Liability, Noncurrent $16,036,000 USD -18%
Liabilities $31,581,000 USD -22%
Accumulated Other Comprehensive Income (Loss), Net of Tax $142,000 USD 33%
Retained Earnings (Accumulated Deficit) $449,624,000 USD 4.6%
Stockholders' Equity Attributable to Parent $126,152,000 USD 29%
Liabilities and Equity $157,733,000 USD 14%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $53,410,000 USD
Net Cash Provided by (Used in) Financing Activities $32,000 USD -99%
Net Cash Provided by (Used in) Investing Activities $8,547,000 USD
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 56,943,413 shares 0.75%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $61,989,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $31,691,000 USD 31%
Deferred Tax Assets, Valuation Allowance $127,585,000 USD 15%
Deferred Tax Assets, Gross $132,230,000 USD 13%
Operating Lease, Liability $22,185,000 USD -12%
Depreciation $87,000 USD 1.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $21,533,000 USD 46%
Lessee, Operating Lease, Liability, to be Paid $26,050,000 USD -14%
Property, Plant and Equipment, Gross $2,529,000 USD 0%
Operating Lease, Liability, Current $3,634,000 USD 9.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two $4,599,000 USD 2.7%
Lessee, Operating Lease, Liability, to be Paid, Year One $4,477,000 USD 2.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3,865,000 USD -24%
Lessee, Operating Lease, Liability, to be Paid, Year Three $4,724,000 USD 2.7%
Deferred Tax Assets, Operating Loss Carryforwards $78,879,000 USD 14%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $3,926,000 USD -17%
Operating Lease, Payments $1,109,000 USD 2.7%
Additional Paid in Capital $575,626,000 USD 1.3%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $4,645,000 USD -22%
Share-based Payment Arrangement, Expense $6,852,000 USD -35%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%